Nice Pharmaceuticals Private Limited

Nice Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U24232DL2009PTC193907 Incorporated 03 September 2009 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹4.49 Cr
▲ 5% YoY
Net profit · FY 2025
₹26.25 Lakh
Net margin 5.8%
EBITDA · FY 2025
₹45.29 Lakh
EBITDA margin 10.1%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹35.27 Lakh
Issued & subscribed
Open charges
₹3.19 Cr
Satisfied ₹1.4 Cr
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings

About Nice Pharmaceuticals Private Limited

Data last updated:

Nice Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 September 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2009PTC193907. Its GSTIN is 06AADCN0892M1Z5 (Haryana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹35.27 Lakh. It is led by directors Jagdeep Singh and Simmi Gujral.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No 314 Plot No. A – 4/1 3rd Floor Usha Kiran Building Naniwala Bagh Landmark Near Aak, Ash Cinema, Delhi, India – 110033.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.49 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹26.25 Lakh (net margin 5.8%) and EBITDA of ₹45.29 Lakh (EBITDA margin 10.1%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 1% over five years.

As per MCA filings, the company has open charges of ₹3.19 Cr and satisfied charges of ₹1.4 Cr on record. Court records list 8 cases involving the company, including 3 filed by the company and 4 filed against it; 5 cases are pending.

Nice Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-18-0013838). The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Nice Pharmaceuticals Private Limited
CIN U24232DL2009PTC193907
Registration Number 193907
Incorporation Date 03 September 2009
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-18-0013838
Key People
Jagdeep Singh Director Simmi Gujral Director

Recognitions & Rankings of Nice Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-HR-18-0013838
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Office No 314 Plot No. A – 4/1 3rd Floor Usha Kiran Building Naniwala Bagh Landmark Near Aak, Ash Cinema, Delhi, India – 110033
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Nice Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Nice Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Nice Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Nice Pharmaceuticals Private Limited

The main business activity of Nice Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Nice Pharmaceuticals Private Limited FY 2025 filings available

Nice Pharmaceuticals Private Limited reported revenue of ₹4.49 Cr (up 5% YoY) for FY 2025.

Revenue · FY 2025
₹4.49 Cr ▲ 5%
Net profit · FY 2025
₹26.25 Lakh margin 5.8%
EBITDA · FY 2025
₹45.29 Lakh margin 10.1%

Compounded Annual Growth Rate (CAGR) of Nice Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▼ 6%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▲ 10%
5 years · compounded
▲ 21%

Revenue rose 5% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Nice Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹45.29 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹26.25 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Nice Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin10.1%••••••••••••••••
Net Profit Margin5.8%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nice Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Nice Pharmaceuticals Private Limited

Nice Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Jagdeep SinghDirector03 Sep 200917 Years 1 MonthsCurrent
Simmi GujralDirector03 Sep 200917 Years 1 MonthsCurrent
View all directors

Peer Comparison of Nice Pharmaceuticals Private Limited

Nice Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pacific Bioengineering Private Limited₹4.51 Cr (FY 2024)••••••••-22.0%••••Delhi, India
S N D Life Science Private Limited₹4.5 Cr (FY 2024)••••••••98.0%••••Navi Mumbai, Maharashtra, India
Astrazen Pharmaceuticals Private Limited₹4.5 Cr (FY 2025)••••••••4.0%••••Panchkula, Haryana, India
Nova Global Medicare Private Limited₹4.5 Cr (FY 2025)••••••••-4.0%••••Kolhapur, Maharashtra, India
S P M Drugs Private Limited₹4.49 Cr (FY 2025)••••••••-30.0%••••Erode, Tamil Nadu, India
Nice Pharmaceuticals Private Limited this company₹4.49 Cr (FY 2025)••••••••5.0%••••Delhi, India
Laxmi Pharmaceuticals Private Limited₹4.49 Cr (FY 2024)••••••••10.0%••••Navi Mumbai, Maharashtra, India
V C Pharmaceuticals (India) Private Limited₹4.48 Cr (FY 2025)••••••••1.0%••••Paravur, Kerala, India
Redson Laboratories Private Limited₹4.47 Cr (FY 2025)••••••••144.0%••••Ahmedabad, Gujarat, India
Lee Morten Life Sciences Private Limited₹4.46 Cr (FY 2025)••••••••12.0%••••Kozhikode, Kerala, India
Nikem Drugs Private Limited₹4.46 Cr (FY 2025)••••••••-53.0%••••Indore, Madhya Pradesh, India

Peers are the five companies nearest above and the five nearest below Nice Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Nice Pharmaceuticals Private Limited

Nice Pharmaceuticals Private Limited is audited by KG SHARMA & CO for the financial year 2023.

NameStatusAppointment DateCessation Date
KG SHARMA & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Nice Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Nice Pharmaceuticals Private Limited

Open charges
₹3.19 Cr
Satisfied charges
₹1.4 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹2.29 Cr
Kotak Mahindra Bank Limited₹0.90 Cr
Latest charge details
DateLenderAmountStatus
15 Jun 2024Hdfc Bank Limited₹2.29 CrOpen
09 Mar 2015Kotak Mahindra Bank Limited₹90 LakhOpen
28 Jan 2011Indian Overseas Bank₹1.4 CrSatisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Nice Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Nice Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Nice Pharmaceuticals Private Limited

Nice Pharmaceuticals Private Limited has 2 board changes on record since 2009: 2 appointments. The latest: Jagdeep Singh was appointed as Director on 03 Sep 2009.

AGM
Nice Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nice Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 229.00 Lakh with Charge ID 100945357 was registered on 15 Jun 2024.
Charges
A charge with Kotak Mahindra Bank Limited amounted to Rs. 90.00 Lakh with Charge ID 10554086 was registered on 09 Mar 2015.
Charges
A charge registered on 28 Jan 2011 via Charge ID 10269838 with Indian Overseas Bank was fully satisfied on 26 Feb 2015.
Charges
A charge with Indian Overseas Bank amounted to Rs. 140.00 Lakh with Charge ID 10269838 was registered on 28 Jan 2011.
Appointed
Jagdeep Singh was appointed as Director.
Appointed
Simmi Gujral was appointed as Director.
Incorporation
03 Sep 2009
Nice Pharmaceuticals Private Limited was registered on 03 Sep 2009 with Roc Delhi & aged 17 years 1 month as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Nice Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Nice Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Nice Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Nice Pharmaceuticals Private Limited

Nice Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
06AADCN0892M1Z5HaryanaActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Nice Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nice Pharmaceuticals Private Limited

Nice Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 September 2009 (17+ years old) and is registered under CIN U24232DL2009PTC193907.

Nice Pharmaceuticals reported revenue of ₹4.49 Cr for FY 2025 (up 5% YoY).

Nice Pharmaceuticals has 2 current directors:

Nice Pharmaceuticals reported a net profit of ₹26.25 Lakh (net margin 5.8%) and EBITDA of ₹45.29 Lakh (EBITDA margin 10.1%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Nice Pharmaceuticals is -6% over three years and -1% over five years. In the latest year (FY 2025) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Nice Pharmaceuticals is 06AADCN0892M1Z5, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Nice Pharmaceuticals is U24232DL2009PTC193907. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nice Pharmaceuticals has 8 court cases on record: 3 filed by the company and 4 filed against it. 5 are pending. Most are in the high courts.

Nice Pharmaceuticals was incorporated on 03 September 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Nice Pharmaceuticals by revenue are Pacific Bioengineering Private Limited, S N D Life Science Private Limited, Astrazen Pharmaceuticals Private Limited, Nova Global Medicare Private Limited, S P M Drugs Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).

Jagdeep Singh was appointed as Director on 03 Sep 2009. Simmi Gujral was appointed as Director on 03 Sep 2009.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available